2021 third quarter inspection report_Guangdong Otsuka Pharmaceutical Co., Ltd.，Rinse，Oral Solution，Basic Infusion

A few days ago, the Center for Drug Evaluation of the State Food and Drug Administration released the "Annual Report on the Status of Clinical Trials of New Drug Registration in China (2020)" (hereinafter referred to as the "Report"). Based on the registration information of the 2020 drug clinical trial registration and information publicity platform, the "Report" is the first to conduct a comprehensive summary and analysis of the current status of new drug registration clinical trials in my country.

广东大冢制药有限公司

2021 third quarter inspection report

2021 third quarter inspection report

Related News

Environmental Protection Test Report for the First Quarter of 2021

Environmental Protection Test Report for the Second Quarter of 2021

2020 New Drug Registration Clinical Trial Status Report Released

Guangdong Otsuka Pharmaceutical Co., Ltd.

0757-28305861